Cell Therapy for Bronchopulmonary Dysplasia: Promises and Perils

被引:18
作者
Moebius, Marius Alexander [1 ,2 ,3 ]
Thebaud, Bernard [3 ,4 ]
机构
[1] Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Fac Med, Dept Neonatol & Pediat Crit Care Med, Dresden, Germany
[2] Tech Univ Dresden, DFG Res Ctr & Cluster Excellence Regenerat Thera, Dresden, Germany
[3] Univ Ottawa, Ottawa Hosp Res Inst, Sinclair Ctr Regenerat Med, Sprott Ctr Stem Cell Res, Ottawa, ON, Canada
[4] Univ Ottawa, Childrens Hosp Eastern Ontario, Dept Pediat, Div Neonatol, Ottawa, ON, Canada
关键词
bronchopulmonary dysplasia; lung; injury; stem cells; mesenchymal stromal cells; cell therapy; MESENCHYMAL STEM-CELLS; ENDOTHELIAL PROGENITOR CELLS; INDUCED LUNG INJURY; PULMONARY ARTERIAL-HYPERTENSION; COLONY-FORMING CELLS; STROMAL CELLS; BONE-MARROW; PRETERM INFANTS; CORD BLOOD; ANIMAL-MODELS;
D O I
10.1016/j.prrv.2016.06.001
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Despite great achievements in neonatal and perinatal medicine over the past decades, the immature lung remains the most critical organ to care for after premature birth. As a consequence, bronchopulmonary dysplasia (BPD) remains the most common complication of extreme prematurity. BPD impairs normal development and may cause lifelong morbidities. At present, there is no effective treatment for BPD including preventing premature birth. Recent insights into the biology of stem and progenitor cells have ignited the hope of protecting the immature lung, and even regenerating an already damaged lung by using exogenous stem- or progenitor cells as therapeutics. These therapies are still experimental, and knowledge on the exact mechanisms behind the beneficial effects seen in various animal models of BPD is limited. Nevertheless, early phase clinical trials have started, and encouraging steps towards the therapeutic use of these cells are being made. This review aims to (I) provide an overview of the role of stem/progenitor cells in development and therapy of BPD for the practicing clinician, (II) discuss the potential clinical applications of cell products as therapeutic agents to prevent neonatal lung injury and (III) examine potential obstacles towards the manufacturing of clinical grade cell products for use in the care for premature infants. (C) 2016 Elsevier Ltd. All rights reserved.
引用
收藏
页码:33 / 41
页数:9
相关论文
共 95 条
[1]   Existence, Functional Impairment, and Lung Repair Potential of Endothelial Colony-Forming Cells in Oxygen-Induced Arrested Alveolar Growth [J].
Alphonse, Rajesh S. ;
Vadivel, Arul ;
Fung, Moses ;
Shelley, William Chris ;
Critser, Paul John ;
Ionescu, Lavinia ;
O'Reilly, Megan ;
Ohls, Robin K. ;
McConaghy, Suzanne ;
Eaton, Farah ;
Zhong, Shumei ;
Yoder, Merv ;
Thebaud, Bernard .
CIRCULATION, 2014, 129 (21) :2144-+
[2]   Bone Marrow Stromal Cells Attenuate Lung Injury in a Murine Model of Neonatal Chronic Lung Disease [J].
Aslam, Muhammad ;
Baveja, Rajiv ;
Liang, Olin D. ;
Fernandez-Gonzalez, Angeles ;
Lee, Changjin ;
Mitsialis, S. Alex ;
Kourembanas, Stella .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 180 (11) :1122-1130
[3]   Endothelial colony-forming cell conditioned media promote angiogenesis in vitro and prevent pulmonary hypertension in experimental bronchopulmonary dysplasia [J].
Baker, Christopher D. ;
Seedorf, Gregory J. ;
Wisniewski, Benjamin L. ;
Black, Claudine P. ;
Ryan, Sharon L. ;
Balasubramaniam, Vivek ;
Abman, Steven H. .
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2013, 305 (01) :L73-L81
[4]   Cord blood angiogenic progenitor cells are decreased in bronchopulmonary dysplasia [J].
Baker, Christopher D. ;
Balasubramaniam, Vivek ;
Mourani, Peter M. ;
Sontag, Marci K. ;
Black, Claudine P. ;
Ryan, Sharon L. ;
Abman, Steven H. .
EUROPEAN RESPIRATORY JOURNAL, 2012, 40 (06) :1516-1522
[5]   Endothelial Colony-forming Cells from Preterm Infants Are Increased and More Susceptible to Hyperoxia [J].
Baker, Christopher D. ;
Ryan, Sharon L. ;
Ingram, David A. ;
Seedorf, Gregory J. ;
Abman, Steven H. ;
Balasubramaniam, Vivek .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 180 (05) :454-461
[6]   Hyperoxia reduces bone marrow, circulating, and lung endothelial progenitor cells in the developing lung: implications for the pathogenesis of bronchopulmonary dysplasia [J].
Balasubramaniam, Vivek ;
Mervis, Cela F. ;
Maxey, Anne M. ;
Markham, Neil E. ;
Abman, Steven H. .
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2007, 292 (05) :L1073-L1084
[7]   Bone marrow-derived angiogenic cells restore lung alveolar and vascular structure after neonatal hyperoxia in infant mice [J].
Balasubramaniam, Vivek ;
Ryan, Sharon L. ;
Seedorf, Gregory J. ;
Roth, Emily V. ;
Heumann, Thatcher R. ;
Yoder, Mervin C. ;
Ingram, David A. ;
Hogan, Christopher J. ;
Markham, Neil E. ;
Abman, Steven H. .
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2010, 298 (03) :L315-L323
[8]   Circulating and Tissue Resident Endothelial Progenitor Cells [J].
Basile, David P. ;
Yoder, Mervin C. .
JOURNAL OF CELLULAR PHYSIOLOGY, 2014, 229 (01) :10-16
[9]   Animal models of bronchopulmonary dysplasia. The term mouse models [J].
Berger, Jessica ;
Bhandari, Vineet .
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2014, 307 (12) :L936-L947
[10]   Stem Cell Therapy for Neonatal Diseases Associated with Preterm Birth [J].
Borghesi, Alessandro ;
Cova, Claudia ;
Gazzolo, Diego ;
Stronati, Mauro .
JOURNAL OF CLINICAL NEONATOLOGY, 2013, 2 (01) :1-7